Employment Law Now VI-121 - Top 5 Fall Things You Need To Know
6 Key Takeaways | Whistleblower Programs: How the U.S. Government Seeks to Create a Speak-Up Culture & Parts of the World Want One Too
Labor & Employment Symposium - Topics: Remote Work; Handling Leaves of Absence; Vaccination Incentives Under Wellness Programs
#WorkforceWednesday: OSHA ETS in Review, Texas Vaccine Mandate Ban, Health Premium Incentives - Employment Law This Week®
Susan Roberts on Creating a Compliance Program Book
Investing in Colombia: Nearshoring & Economic Incentives in Manufacturing, Technology, Infrastructure, and Energy Industries
Williams Mullen's Comeback Plan: North Carolina’s COVID-19 Job Retention Program
Drug Pricing Initiatives During the Trump Presidency
PODCAST: Wellness Program Compliance Update
FCPA Pilot Program
Day 20 - Compliance Leadership from the Bottom
Unfair and Unbalanced-Episode 18
Day 13 of One Month to Better Compliance Thru HR
Day 11 of One Month to Better Compliance Through HR-the Fair Process Doctrine
This Week in FCPA- Episode 52, for the week ending May 12, the Firing the Investigators Edition
Day 10 Of One Month to Better Compliance through HR-Sales Incentives and Compliance
Day 8 of One Month to Better Compliance Through HR-Using Compensation to Operationalize Compliance
Day 7 Of One Month To Better Compliance Through HR - Six Principles For Compliance Incentives
Day 6 of One Month to Better Compliance Through HR-Incentivizing Compliance
Ten Hallmarks of an Effective Compliance Program-Hallmark 6
The Cozen Lens - While it’s becoming ever clearer Vice President Harris is likely to be the Democratic nominee following President Biden’s decision to step aside, it’s less clear what the impact will be on the presidential...more
We always focus on foreign bribery — the FCPA and corporate bribery of foreign officials. It is certainly a problem that undermines economic development and human rights. ...more
The U.S. health insurance provider Cigna has provided a financial incentive to patients who switch to an infliximab biosimilar, through a one-time $500 debit card for health care services and products called the “Shared...more
In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs, the Trump administration has proposed a series of changes to the...more
In October 2018, the Canadian Agency for Drugs and Technologies in Health (CADTH) issued an interesting Environmental Scan on International Policies on the Appropriate Use of Biosimilar Drugs (Report). This Report outlines...more
Our local pharmaceutical environment is highly regulated.The most important legislative provisions are found in the Medicines Act and the Pharmacy Act....more
On Feb. 9, 2018, the Trump Administration released a 30-page report analyzing domestic and global factors influencing drug pricing. The report by the Council of Economic Advisers (CEA) is expected to inform the HHS' Fiscal...more
Last week, the California Assembly Committee on Business and Professions voted in favor of Assembly Bill 315. AB 315 seeks to amend the California Business and Professions Code: (a) to require PBMs to obtain licensure from...more
According to a report released July 6, 2015 by the Government Accountability Office (GAO), hospitals that qualify to participate in the 340B Drug Pricing Program by virtue of their serving a disproportionate share of...more